Biotech Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria July 22, 2022
Biotech BridgeBio Pharma Announces Academic Collaboration with Baylor College of Medicine to Advance Potential Therapies to Treat Genetic Diseases July 22, 2022
Biotech Bragar Eagel & Squire, P.C. Is Investigating Cassava, Hannon Armstrong, and Nio and Encourages Investors to Contact the Firm July 21, 2022
Biotech Myovant Sciences to Host First Fiscal Quarter 2022 Earnings Conference Call at 5:00 p.m. Eastern Time on July 27, 2022 July 13, 2022
Biotech Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors July 11, 2022
Biotech Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities July 1, 2022
Biotech Celldex Therapeutics Presents Positive Interim Data from Barzolvolimab Phase 1b Study in Chronic Spontaneous Urticaria at EAACI 2022 July 1, 2022